VIM and esophageal squamous cell carcinoma: miR-301a targets the tumor-promoting factor WNT1 to increase the radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells, while suppressing drug resistance and EMT by targeting Snail and Vimentin [11].